AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 84 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,000 | -99.4% | 1,000 | -98.8% | 0.00% | – |
| Q4 2015 | $818,000 | +6192.3% | 85,917 | +5372.4% | 0.00% | – |
| Q3 2015 | $13,000 | -98.9% | 1,570 | -97.9% | 0.00% | – |
| Q2 2015 | $1,236,000 | +123500.0% | 76,114 | +362347.6% | 0.00% | – |
| Q1 2015 | $1,000 | -99.6% | 21 | -99.5% | 0.00% | – |
| Q4 2014 | $226,000 | – | 4,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|